The company is constantly improving operations and manufacturing processes to scale up the quality of manufacturing and minimize its harmful effects on the environment. «Grindeks» is investing considerably in its manufacturing technology and infrastructure development annually, ensuring high quality of medication and active pharmaceutical ingredients, confirming its loyalty to the UN Global Compact movement objectives.
Taking into account the UN Global Compact principles, «Grindeks» is especially committed to quality and safety requirements and standards, which are particularly high in the pharmaceutical industry. «Grindeks» respects international and Latvian manufacturing standards and is responsible for the quality of its products.
The pharmaceutical production is one of the most responsible fields of manufacturing, as it relates to human life and health, therefore the pharmaceutical industry is faced to particularly high quality requirements. «Grindeks» is certified and operates under the Good Manufacturing Practice standard, which also serves as a guarantee that «Grindeks» is working according to the European Union’s and the world’s requirements.
«Grindeks» manufacturing units are inspected several times annually by both global pharmaceutical inspection and partner audits, providing an opinion on compliance with international quality standards.
Good Manufacturing Practice